Synexa is a global leader in biomarker and bioanalytical science, with deep expertise in the immunological underpinning of health and disease.

We offer a comprehensive range of analytical and advisory services to clients comprising the identification, development, validation, analysis and interpretation of biomarker and bioanalytical readouts in translational and clinical research. Our developing global network of labs serve our client base of primarily Biotech and Pharma companies, either directly or via a CRO.

We are dedicated to providing quality, clinically relevant solutions, and all activities across all our sites are performed in compliance with GCLP which incorporate the relevant GCP/GLP guidelines, under the guidance and watchful eyes of our Quality Assurance team.